169.48
-1.19 (-0.7%)
-1.19 (-0.7%)
Upgrade to Real-Time
Premarket
| Volume | 7,977 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Johnson and Johnson | JNJ | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -1.19 | -0.7% | 169.48 | 07:21:16 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 170.67 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 594 | 7,977 | - | 155.72 - 186.69 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 07:22:57 | 1 | $ 169.63 | USD |
Period:
Draw Mode:
Johnson and Johnson Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 445.65B | 2.63B | 2.63B | $ 93.78B | $ 17.95B | 7.81 | 24.80 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 4.19 | 2.65% | 08/22/22 | -47.64k | 0.20% |
Johnson and Johnson News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical JNJ Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 174.60 | 175.09 | 169.4354 | 170.81 | 5,330,552 | -5.12 | -2.93% |
| 1 Month | 172.53 | 178.51 | 169.4354 | 172.81 | 5,891,406 | -3.05 | -1.77% |
| 3 Months | 174.72 | 183.3506 | 167.26 | 175.37 | 6,673,705 | -5.24 | -3.0% |
| 6 Months | 169.12 | 186.69 | 155.72 | 175.05 | 7,357,534 | 0.36 | 0.21% |
| 1 Year | 174.01 | 186.69 | 155.72 | 170.82 | 7,215,195 | -4.53 | -2.6% |
| 3 Years | 131.50 | 186.69 | 109.16 | 155.09 | 7,496,829 | 37.98 | 28.88% |
| 5 Years | 133.64 | 186.69 | 109.16 | 147.63 | 7,096,810 | 35.84 | 26.82% |
Johnson and Johnson Description
| Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. Geographically, just over half of total sales are generated in the United States. |